Error loading player: No playable sources found
2525
Irritable Bowel Syndrome Clinical
Date
May 18, 2024
SOCIETY: AGA
Presentations:
| TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL |
| IS A SIMPLIFIED LOW FODMAP RESTRICTION PHASE POSSIBLE? RESULTS FROM A MULTI-CENTER, DOUBLE-BLIND, PILOT-FEASIBILITY, RANDOMIZED CONTROLLED TRIAL |
| DIFFERENCES IN DIETARY INTAKE PATTERNS CONTRIBUTE TO VARIATIONS IN THE WORLDWIDE PREVLANECE OF ROME IV IRRITABLE BOWEL SYNDROME |
| PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PROOF OF CONCEPT STUDY OF EFFICACY OF RIFAMYCIN SV-MMX® 600 MG ADMINISTERED THREE OR TWO TIMES DAILY TO PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) |
| EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY |
| APP-DELIVERED GUT-DIRECTED HYPNOTHERAPY IS SUPERIOR TO PSYCHOEDUCATION IN REDUCING SYMPTOMS ASSOCIATED WITH IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROL TRIAL |
Moderators
Mayo Clinic Scottsdale
Cleveland Clinic
Speakers
University of Michigan
Michigan Medicine
Tracks
Related Products
Enteric Neuromuscular Biology Cell and Molecular Biology
C1QA MUSCULARIS MACROPHAGES: A DYNAMIC PLAYER IN THE REGULATION OF SYNAPTIC FUNCTION AND EXPRESSION
AGA Irritable Bowel Syndrome: Pathophysiology
SOCIETY: AGA
AGA Frances and Don W. Powell, MD, Lecture: New Treatments for Bile Acid Diarrhea
Bile acid diarrhea is a poorly recognized cause of bowel symptoms. The pathophysiology is varied and includes bile acid overproduction and malabsorption. Recent studies have provided new evidence of targets for therapy and will be reviewed in this session…
